Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Peer Review reports

From: Long acting β2agonists for stable chronic obstructive pulmonary disease with poor reversibility: a systematic review of randomised controlled trials

Original Submission
16 Sep 2003 Submitted Original manuscript
5 Oct 2003 Reviewed Reviewer Report - Mario Cazzola
6 Oct 2003 Reviewed Reviewer Report - Piersante Sestini
18 Nov 2003 Reviewed Reviewer Report - Elmer Villanueva
Resubmission - Version 2
Submitted Manuscript version 2
27 Feb 2004 Author responded Author comments - Donald Husereau
Resubmission - Version 3
27 Feb 2004 Submitted Manuscript version 3
31 Mar 2004 Reviewed Reviewer Report - Piersante Sestini
6 Aug 2004 Author responded Author comments - Donald Husereau
Resubmission - Version 4
6 Aug 2004 Submitted Manuscript version 4
Publishing
31 Aug 2004 Editorially accepted
31 Aug 2004 Article published 10.1186/1471-2466-4-7

You can find further information about peer review here.

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us